PharmaCyte Biotech (PMCB) EBT Margin (2010 - 2012)
PharmaCyte Biotech (PMCB) posted quarterly EBT Margin of 6617.83% for Q4 2012, down 441489.0% year-over-year from N/an in Q4 2011, and up 25.02% quarter-over-quarter from 8826.58% in Q3 2012.
PharmaCyte Biotech (PMCB) EBT Margin (2010 - 2012) Analysis & Trends
PharmaCyte Biotech (PMCB) has reported EBT Margin for 3 consecutive years, with 6617.83% the latest figure, recorded in Q4 2012.
- In Q4 2012, EBT Margin fell 441489.0% year-over-year to 6617.83%; the TTM figure through Jul 2013 stood at 41786.43% (down 3789649.0% YoY), while the FY2013 annual figure was 116294.28%, down 11302006.0% from the prior year.
- EBT Margin grew to 6617.83% in Q4 2012 per PMCB's latest filing, from 8826.58% in the prior quarter.
- Across five years, EBT Margin topped out at 47.04% in Q4 2010 and bottomed at 9135.55% in Q2 2012.
- Historically, EBT Margin has averaged 3357.42% across 3 years, with a median of 2200.92% in 2011.
- On a YoY basis, EBT Margin climbed as much as 215691 bps in 2012 and fell as far as 810002 bps in 2012.
- PharmaCyte Biotech's EBT Margin stood at 47.04% in 2010, then slumped by 4784 bps to 2202.94% in 2011, then sank by 200 bps to 6617.83% in 2012.
- Business Quant data shows PMCB's EBT Margin at 6617.83% in Q4 2012, 8826.58% in Q3 2012, and 9135.55% in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.96 Bn | 132.11 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 60.20 Bn | 55.06 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 42.19 Bn | 37.09 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 31.43 Bn | 28.12 Bn | 992.69 Mn | 13.77% |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | -25.06% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 12.09% |
| 10 | PharmaCyte Biotech | 4.44 Mn | 4.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -6,617.83% |
| Jul 31, 2012 | -8,826.58% |
| Apr 30, 2012 | -9,135.55% |
| Jan 31, 2012 | -2,198.90% |
| Oct 31, 2011 | -2,202.94% |
| Jul 31, 2011 | -3,471.41% |
| Apr 30, 2011 | -1,035.53% |
| Jan 31, 2011 | -41.99% |
| Oct 31, 2010 | 47.04% |
| Jul 31, 2010 | -90.55% |